Smith & Nephew (SN.) — Dividend Yield: 2.36%

Smith & Nephew (LON: SN.) is a global medical technology company specialising in orthopaedic reconstruction, sports medicine, and advanced wound care products. Its technologies are widely used in hospitals and clinics around the world.

Smith & Nephew's dividend yield of approximately 2.36% provides steady income supported by consistent cash flows from healthcare demand. Ageing populations globally continue to drive demand for joint replacement procedures.

For investors seeking healthcare exposure within the FTSE 100, Smith & Nephew offers access to long-term structural growth in medical technology and surgical innovation.